ImmunoPET With an Anti-CD8 Imaging Agent
NCT04029181
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
47
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Cancer
Unresectable Malignant Neoplasm
Interventions
OTHER:
Anti-CD8 PET imaging agent
Sponsor
University Medical Center Groningen